Visa Suomi, MathWorks
Simon Sonntag, Virtonomy
Martin Witte, TÜV SÜD
In silico medicine uses computational modeling and simulation (CM&S) for the design, testing, and clinical evaluation of medical devices. Many companies in the medical devices industry have already adopted in silico medicine for their R&D, and regulators such as the FDA use CM&S to provide supportive regulatory evidence for market approvals.
But what is the current industry and regulatory view on in silico medicine and how you can get started in your organization? Join this roundtable webinar to learn how industry leaders see the current stage of in silico medicine in the research and development of next-generation medical devices.
Highlights
- Validity and Reliability: Are the computational models and simulations used for medical devices valid and reliable?
- Safety and Efficacy: How can computational simulations assess the safety and efficacy of medical devices?
- Optimization and Design: How can computational methods optimize the design and performance of medical devices?
- Regulatory Compliance: What are the regulatory requirements for using computational models in medical device development?
- Clinical Translation: How can computational simulations bridge the gap between preclinical testing and clinical trials?
- Data Requirements: What data is needed to develop and validate computational models for medical devices?
- Collaboration and Interdisciplinary Approach: How can interdisciplinary collaboration be fostered to leverage in silico medicine in medical device development?
